Bevacizumab versus anti–epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block?

Michel Ducreux; Jean Pierre Pignon

doi:10.1016/j.ejca.2016.10.001

Bevacizumab versus anti–epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block?

Michel Ducreux, Jean Pierre Pignon

Résultats de recherche: Contribution à un journal › Editorial

2 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	178-179
Nombre de pages	2
journal	European Journal of Cancer
Volume	69
Les DOIs	https://doi.org/10.1016/j.ejca.2016.10.001
état	Publié - 1 déc. 2016

Accès au document

10.1016/j.ejca.2016.10.001

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{ac8bd88d13ab4186be6ac7ebc415388a,

title = "Bevacizumab versus anti–epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block?",

author = "Michel Ducreux and Pignon, {Jean Pierre}",

year = "2016",

month = dec,

day = "1",

doi = "10.1016/j.ejca.2016.10.001",

language = "English",

volume = "69",

pages = "178--179",

journal = "European Journal of Cancer",

issn = "0959-8049",

}

TY - JOUR

T1 - Bevacizumab versus anti–epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis

T2 - The last building block?

AU - Ducreux, Michel

AU - Pignon, Jean Pierre

PY - 2016/12/1

Y1 - 2016/12/1

UR - http://www.scopus.com/inward/record.url?scp=84994234823&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2016.10.001

DO - 10.1016/j.ejca.2016.10.001

M3 - Editorial

C2 - 27835821

AN - SCOPUS:84994234823

SN - 0959-8049

VL - 69

SP - 178

EP - 179

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -